C3orf26 Polyclonal Antibody, FITC Conjugated
Product Specifications
Background
Chromosome 3 is made up of about 214 million bases encoding over 1,100 genes. Notably, there is a chemokine receptor gene cluster and a variety of human cancer related loci on chromosome 3. Particular regions of the chromosome 3 short arm are deleted in many types of cancer cells. Key tumor suppressing genes on chromosome 3 encode apoptosis mediator RASSF1, cell migration regulator HYAL1 and angiogenesis suppressor SEMA3B. Marfan Syndrome, porphyria, von Hippel-Lindau syndrome, osteogenesis imperfecta and Charcot-Marie-Tooth Disease are a few of the numerous genetic diseases associated with chromosome 3. The C3orf26 gene product has been provisionally designated C3orf26 pending further characterization.
Synonyms
C3orf26; CC026_HUMAN; MGC4308; Uncharacterized protein C3orf26.
Cellular Locus
Nucleus
Host
Rabbit
Cross Reactivity
Human
Immunogen
101-200/279
Target
C3orf26
Clonality
Polyclonal
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human C3orf26
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
1µg/µl
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Product Datasheet
https://www.biossantibodies.com/datasheets/bs-15171R-FITC
Predicted Cross Reactivity
Mouse, Rat, Horse
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
